Compare EVO & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | NEOG |
|---|---|---|
| Founded | 1993 | 1981 |
| Country | Germany | United States |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 821.2M | 2.3B |
| IPO Year | N/A | 1995 |
| Metric | EVO | NEOG |
|---|---|---|
| Price | $2.42 | $9.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $10.67 |
| AVG Volume (30 Days) | 105.5K | ★ 2.3M |
| Earning Date | 01-01-0001 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $894,661,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.13 | $1.67 |
| P/E Ratio | ★ N/A | $101.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $3.87 |
| 52 Week High | $4.80 | $11.43 |
| Indicator | EVO | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 27.25 | 31.74 |
| Support Level | N/A | $8.93 |
| Resistance Level | $3.78 | $10.30 |
| Average True Range (ATR) | 0.10 | 0.45 |
| MACD | -0.10 | -0.27 |
| Stochastic Oscillator | 8.81 | 9.31 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.